<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1CDD62DF-93A7-45FD-9624-3EBB0ABF5D07"><gtr:id>1CDD62DF-93A7-45FD-9624-3EBB0ABF5D07</gtr:id><gtr:name>National Disease and Research Interchange (NDRI)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1CDD62DF-93A7-45FD-9624-3EBB0ABF5D07"><gtr:id>1CDD62DF-93A7-45FD-9624-3EBB0ABF5D07</gtr:id><gtr:name>National Disease and Research Interchange (NDRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/38A1C3CA-0789-4B59-85A7-41260AE339CF"><gtr:id>38A1C3CA-0789-4B59-85A7-41260AE339CF</gtr:id><gtr:firstName>Donald</gtr:firstName><gtr:surname>Mitchell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2735F8CB-B1F6-4566-A8EA-7434499EA3D0"><gtr:id>2735F8CB-B1F6-4566-A8EA-7434499EA3D0</gtr:id><gtr:firstName>Ajit</gtr:firstName><gtr:surname>Lalvani</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1DF2C52F-A2B5-4F6F-A6D3-EDE5392920AA"><gtr:id>1DF2C52F-A2B5-4F6F-A6D3-EDE5392920AA</gtr:id><gtr:firstName>Sanjeev</gtr:firstName><gtr:surname>Krishna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/59AC2E57-B584-4E7F-8D5B-B7166756B4CE"><gtr:id>59AC2E57-B584-4E7F-8D5B-B7166756B4CE</gtr:id><gtr:firstName>Judit</gtr:firstName><gtr:otherNames>Maria</gtr:otherNames><gtr:surname>Nagy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801620"><gtr:id>409D2C76-5618-46C0-B0ED-F91B52B222FB</gtr:id><gtr:title>Identification of antigen specific T-cells for diagnosis of sarcoidosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801620</gtr:grantReference><gtr:abstractText>Sarcoidosis is a potentially fatal disease that can affect any organ within the body. It is due to the
build up of clumps of tissue called granulomas. Current diagnosis involves a needle-biopsy of a
granuloma which can have complications such as bleeding or infection. The Kveim reaction is an old test which involved injecting a piece of sarcoidosis spleen or lymph node into a patient. It often produced a local reaction but we cannot use it anymore due to the potential to transmit infectious diseases. Recent work has shown that the reaction resulted from an influx of special immune cells called T-cells.

We believe we can measure these specific T-cells in the blood of a person to see if they
have the disease, without the need for a biopsy. Our Group has used a similar approach in
tuberculosis and created the first new test for that infection in over 100 years. A new simple T-cell based blood test for sarcoidosis would be revolutionary for patients and lead to important new insights for the disease.</gtr:abstractText><gtr:technicalSummary>Sarcoidosis is a potentially fatal multi-organ granulomatous disease of unknown aeitiology with no simple diagnostic test. The immunopathogenesis is poorly understood and the antigenic targets of the granuloma-associated CD4+ T-cells are unknown. Granulomatous reaction to intrcutaneous innoculation with Kveim reagent was historically used as a sensitive and specific diagnostic tool. The CD4+ T-cell infiltrate that characterises Kveim reaction is oligoclonal, implicating a small number of Kveim reagent-derived protein targets. We will isolate and identify candidate antigens within Kveim reagent using proteomic fingerprinting. Our initial approach will involve 2d gel electrophoresis to identify the candidate proteins. An alternative approach will apply trypsin digests and MALDI to produce peptide mass fingerprints. State of the art bioinformatics will be used to analyse the produced data and identify the novel candidate antigens. In addition, we will perform multiplex cytometric bead-array analysis on blood and bronchoalveolar lavage fluid (incubated with Kveim-derived antigens) from recently diagnosed sarcoidosis patients. These results will be combined to develop a novel ex-vivo antigen specific T-cell assay for use in diagnosis. Ethical approval for the entire project is in place. We have begun collecting patient blood and bronchoalveolar samples and protein work has commenced to identify the novel Kveim-derived candidate antigens.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-12</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>644544</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>CISBIO Mass Spectrometry Facility</gtr:department><gtr:description>CISBIO Mass Spectrometry Facility</gtr:description><gtr:id>E84EB3CE-A6B8-42A6-81B7-43D649C8E65D</gtr:id><gtr:impact>The experimental work is still ongoing - proteins were measured and succesfully identified.</gtr:impact><gtr:outcomeId>jaZUxC8TCUj-1</gtr:outcomeId><gtr:partnerContribution>Access to mass spectrometric equipment will be provided i.e. MALDI and ESI mass spectrometers.</gtr:partnerContribution><gtr:piContribution>Within this collaboration, our task will be the separation of protein samples by 1D- and 2D-SDS- gel electrophoresis, the preparation of digested protein samples and furthermore the data analysis after the mass spectrometric experimental work is our responsibility.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Disease and Research Interchange (NDRI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>National Disease and Research Interchange</gtr:description><gtr:id>417B3A35-C7FC-4212-A049-313BCBC17588</gtr:id><gtr:impact>Future research publications will benefit directly from this collaboration</gtr:impact><gtr:outcomeId>rT3AP7RxFUT-1</gtr:outcomeId><gtr:partnerContribution>They have provided ethically sourced specimens of sarcoidosis and control spleen tissues</gtr:partnerContribution><gtr:piContribution>We have set up a protocol to receive ethically donated human sarcoidosis and control spleen specimens for our work</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Centre for Respiratory Infection</gtr:description><gtr:id>C4A6A9EE-2703-437F-803A-B04C6B313AF9</gtr:id><gtr:impact>The availability of samples taken at time of bronchoscopy from a multi-disciplinary team (medical doctors, scientists and research nurses) has been key to our ongoing scientific work.</gtr:impact><gtr:outcomeId>ThCSYVEAzJ5-1</gtr:outcomeId><gtr:partnerContribution>Provision of asthma and healthy bronchoalveolar lavage samples for our work</gtr:partnerContribution><gtr:piContribution>We have entered into a collaboration with the Centre for Respiratory Infection at Imperial College in order to access bronchoalveolar lavage samples form healthy peoples and those with asthma for use as control samples in our own work. The collaboration was formed after members of the research team approached the centre.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>UCL Cancer Proteomics Institute</gtr:description><gtr:id>1AC57B34-276E-4B56-8C74-2140B56069E5</gtr:id><gtr:impact>The collaboration has allowed us to more accurately scan our DIGE (difference in gel electrophoresis) gels than if we had simply used a white light scanner available at our own institute. The collaboration has involved scientists from UCL working with our own team. This collaboration has been key to our progression to determine proteins of interest for the purposes of our project.</gtr:impact><gtr:outcomeId>n3pAhycrKeY-1</gtr:outcomeId><gtr:partnerContribution>The use of Typhoon laser scanner for our work</gtr:partnerContribution><gtr:piContribution>We have started a collaboration with the Cancer Proteomics Institute at Imperial College London for the purposes of using a Typhoon laser imager to image our protein gels. This piece of equipment costs around &amp;pound;100,000 and we do not have access to our own imager. The collaboration was formed after members of the research team approached the institution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>APAM 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>67B32652-CEEA-4491-B5D5-0ED5ADCCC4AF</gtr:id><gtr:impact>Presented at the 107th Annual meeting of the Association of Physicians of Great Britain and Ireland in Cambridge April 2014</gtr:impact><gtr:outcomeId>56c34fcfe293c9.63586867</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.medschl.cam.ac.uk/message-regius/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Future of Latent TB Screening Plenary Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C9C667A8-3BA7-4EAD-83B3-1A4A8694BFBB</gtr:id><gtr:impact>Presentation at Bellritge University Hospital - IDIBELL - University of Barcelona. Audience including Barcelona Public Health Service.</gtr:impact><gtr:outcomeId>58c7ca43ad4733.70061516</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participated in discuss the LSHTM &amp; UCL World TB day event on 24 March 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>319C3641-8405-484A-AD2C-3A979E8E9173</gtr:id><gtr:impact>Attended a World TB Day event and shared information and research plans with colleagues in other TB research departments</gtr:impact><gtr:outcomeId>56c349b4cdf277.61332293</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.eventbrite.co.uk/e/world-tb-day-2015-what-do-we-need-to-know-to-reach-treat-and-cure-everyone-with-tb-tickets-15601294893</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCP annual conference March 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>13A0EB3A-B74C-49E2-AA1E-9474462BADE1</gtr:id><gtr:impact>Attended Royal College of Physician conference in March 2015</gtr:impact><gtr:outcomeId>56c4a097c26417.18983607</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Vaccine Congress October 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE3614AA-54F2-4BF0-A04A-4C885E1F4F42</gtr:id><gtr:impact>Presented at World Vaccine Congress in Brussels in October 2014</gtr:impact><gtr:outcomeId>56c4a17c37baf3.62996446</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://10times.com/world-vaccine-congress-lille/speakers</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the BSI Congress LIverpool December 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47C1419A-DB96-415C-BC93-4A1BF835A212</gtr:id><gtr:impact>A talk by Robert Parker on Quantitative Analysis of Serum Proteins in Tuberculosis, Sarcoidosis and Other TB-Like Diseases (in relation to this grant).</gtr:impact><gtr:outcomeId>58ca9e3a906ec6.37940556</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Board India Alliance (Wellcome) October 2014</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3950C596-94C2-4737-B897-454C8CA341E6</gtr:id><gtr:impact>Was a member of the India Alliance's Advisory Board held in October 2014 to shape strategy and ensure TB objectives considered</gtr:impact><gtr:outcomeId>56c351b9845c59.34343621</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Attended the Acid Fast Club in Berlin in July 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8837EF3-7551-4BC3-B49D-7332E21859E8</gtr:id><gtr:impact>Attended the 60th anniversary meeting of the Acid Fast Club (mycobacteria research community) in Berlin in 2014 with a TBRU PhD student, AK Reuschl to develop postgraduate student understanding of the broader research agenda</gtr:impact><gtr:outcomeId>56c35083be28e5.85939830</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://acidfastclub.uk/tag/2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at British Society for Immunology Brighton December 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CC2D5AC3-6623-4D14-BBE1-6B511813F7F1</gtr:id><gtr:impact>Presentation on &amp;quot;Preventing infectious disease pandemics with T cells&amp;quot; at the BSI Brighton December 2014</gtr:impact><gtr:outcomeId>56c352f2247093.99893478</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR HPRU Quarterly Symposium TB</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D62EF0BA-819E-4FE4-8491-FC5BACD13631</gtr:id><gtr:impact>NIHR HPRU Quarterly Symposium TB - Organiser of this event</gtr:impact><gtr:outcomeId>58c7d8fbddecf6.55212222</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organiser and Chair of World TB Day Conference at Royal Society of Medicine 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>773EFC02-8A33-4DF7-B2C7-2FFF306DB1A8</gtr:id><gtr:impact>The meeting aims to present the most relevant recent advances in clinical, public heath and scientific aspect of TB with special reference to reducing the national burden of TB in the UK.
This is a highly interactive meeting with meaningful participation of the multi-disciplinary audience in direct discussion with world experts.</gtr:impact><gtr:outcomeId>58c6ca21a7ed65.81755212</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organiser and chair of World TB Day Conference at Royal Society of Medicine March 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0BFC37D2-E2CF-4C71-A409-C53BC9C2B07E</gtr:id><gtr:impact>Organiser and chair of World TB Day Conference at Royal Society of Medicine March 2016</gtr:impact><gtr:outcomeId>56e03ce7c4adb5.15898511</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organised the Royal Society of Medicine's conference: TB in 2016: Rolling out the national strategy</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>72A88FC0-1CEE-492C-B14A-24C4D685E5EF</gtr:id><gtr:impact>Considerable informed debate will be generated about rolling out the national TB strategy in the UK. Nurses, outreach workers, doctors and policy-makers and public health professionals will contribute to the discussion</gtr:impact><gtr:outcomeId>56c32b60b5ca93.90289635</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.rsm.ac.uk/events/events-listing/2015-2016/sections/respiratory-medicine-section/rmg02-tb-in-2016-rolling-out-the-national-strategy.aspx</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engagement to End TB Panel University of East London.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7D9D92FC-BE49-4D78-B916-8BF14569CDDC</gtr:id><gtr:impact>Ajit Lalvani was a key member on the panel at the Engagement to End TB event at the University of East London. This was part of the Voices for London Festival which was attended by community members of East London.</gtr:impact><gtr:outcomeId>58c7da20e24b47.58164114</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the Crick Institute 27/2/14</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B0F1FCE6-6D43-4666-876D-0FD9350CA9EE</gtr:id><gtr:impact>Gave a presentation at the Crick Institute Museam of Science late night event</gtr:impact><gtr:outcomeId>56c345daa87678.91817106</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.crick.ac.uk/news/news-archive/2014/02/27/record-breaking-attendance-at-crick-event/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10th Global Fund Strategy, Investment and Impact Committee (SIIC) Meeting 4 Feb 2014</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>046D1E48-1BB6-47BB-8CE3-1A443E2464E5</gtr:id><gtr:impact>Attended the 10th Global Fund Strategy, Investment and Impact Committee (SIIC) Meeting in Geneva on 4th Feb 2014 to influence policy and funding priorities for this major donor</gtr:impact><gtr:outcomeId>56c34d664d6a30.37494246</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Future of Latent TB Screening</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CC364C2B-09FB-478C-A519-6B64681AC294</gtr:id><gtr:impact>Talk given at XX CONGRESO INTERNACIONAL SOBRE TUBERCULOSIS Fechas de realizaci&amp;oacute;n: 21 y 22 de noviembre de 2016.</gtr:impact><gtr:outcomeId>58c7c7bdd1a9b3.41018894</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Well North Conference, Manchester - Festival of Public Health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7156D022-4C26-46A9-AE27-A6507733CFB3</gtr:id><gtr:impact>A presentation on TB and health inequalities, Bromley-by-Bow model. &amp;quot;Tackling health inequalities (including TB) in East London.</gtr:impact><gtr:outcomeId>58c7ce41705678.00847373</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with Lord Nigel Crisp (Co-chair of the All Party Parliamentary Group on Global Health) 12 March 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E84BE962-A0DE-4B53-8B91-61FD42646E2F</gtr:id><gtr:impact>Discussion with Lord Nigel Crisp about preventing flu and TB pandemics in the UK</gtr:impact><gtr:outcomeId>56c347af0fc102.97988082</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR HPRU in Respiratory Infections Quarterly Symposium Influenza</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF303F99-FADD-4EBF-8600-3B8A7A61FA77</gtr:id><gtr:impact>Quarterly Symposium series - May 25th 2016, Influenza. LAIV Programme Q&amp;amp;Q led by Ajit Lalvani</gtr:impact><gtr:outcomeId>58c7d828b6a0d8.70985976</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Head of culture and society at Wellcome Trust: evaluating impact of work to reverse social determinants of health (and health inequalities)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD11F562-4087-4597-AE4B-96572F54DD33</gtr:id><gtr:impact>Meeting with head of culture and society at Wellcome Trust in April 2015 to plan how to evaluate impact of work to reverse social determinants of health (and health inequalities) at Bromley by Bow Centre.</gtr:impact><gtr:outcomeId>56e03c667b68f6.84817736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11C40622-A5D7-4426-85EC-EBA1D938780A</gtr:id><gtr:impact>Gave a presentation on Prevention of Sustained Mycobacterium tuberculosisInfection: Lessons from Human Natural History and BCG Studies.</gtr:impact><gtr:outcomeId>56c4a6040203e7.36361387</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.sciencedirect.com/science/article/pii/S0264410X15003801</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the World Vaccine Congress 16 October 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0D70EFDD-FA8C-4F18-B161-B5E78439B4EE</gtr:id><gtr:impact>Presentation at the World Vaccine Congress 16 October 2013</gtr:impact><gtr:outcomeId>56c34be79a9a00.21952025</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.globaleventslist.elsevier.com/events/2013/10/world-vaccine-congress-europe-2013/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GeCIP open meeting 5 December 2014</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EFEF99A6-6BC4-42B0-9F93-004501291775</gtr:id><gtr:impact>Attended the Genomics England open meeting on %th December 2014 to engage with colleagues and policymakers</gtr:impact><gtr:outcomeId>56c35428bc5410.29753354</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genomicsengland.co.uk/download/gecip-open-meeting-5-december-2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have created an electronic database to log all clinical samples that have been procured within our tissue bank for the purposes of this project. This database is available to other research groups, who have used sarcoid samples as controls for their own work.</gtr:description><gtr:id>322E959A-8100-413E-8684-21A8F4053375</gtr:id><gtr:impact>This database is available to other research groups, who have used sarcoid samples as controls for their own work (e.g. bronchoalveolar lavage fluid from patients with sarcoidosis have been used as controls for a research project centred on human tuberculosis disease).</gtr:impact><gtr:outcomeId>mxAaEPwWe4D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Sarcoidosis Tissue Database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>LC-MS is used to, separate, identify the sequence, and measure the relative abundance of peptides in protein digests generated from serum samples. With these measurements the protein identity and expression level can be inferred.</gtr:description><gtr:id>8AA1D6A0-E414-4E9F-AE4E-CEDCF092F53C</gtr:id><gtr:impact>This method enables us to perform without bias a discovery experiment that compares the relative abundance of proteins/peptides in serum from patients with Sarcoidosis to patients with active Tuberculosis or those with no known disease. These data reveal a serum protein signature that is specific to Sarcoidosis and is used for the selection of biomarkers.</gtr:impact><gtr:outcomeId>56c4aa1942d506.03523737</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>LC-MS</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The biochemical analysis of unsoluble, proteolytical resistant proteins e.g. glycoproteins often poses methoddological challenges - here we developed a pathway of non-enzymatic protein degradation which enables mass spectrometric analysis.</gtr:description><gtr:id>660F94C7-38E4-4013-A794-C39E3BA72864</gtr:id><gtr:impact>This approach allows to identify proteins hardly amenable to investigations e.g. extracellular matrix proteins.</gtr:impact><gtr:outcomeId>RQMTZjGHS4q</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CNBr Cleavage of proteolytically recalcitrant proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have defined a robust and reproducible method for the removal of toxic substances from spleen proteins that have been precipitated as part of a gel electrophoresis experiment. This method involves removal of substances (e.g. urea) that allow it to be incubated with Peripheral Blood Mononuclear Cells in an overnight assay without toxicity to the cells.</gtr:description><gtr:id>D808AD9E-8103-4260-AACE-1E16F7C016AD</gtr:id><gtr:impact>We aim to publish these methods separately or as part of a larger paper with other results.</gtr:impact><gtr:outcomeId>oCnTpL7NKi4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Multiple Cytokine analysis of human spleen proteins incubated with PBMCs</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a robust and reproducible method for gel electrophoresis of proteins stored in phenol and at at room temperature for long periods of time. These proteins would normally be difficult to analyse using standard electrophoresis techniques.</gtr:description><gtr:id>E0DDBD5D-D3CF-47B8-8307-A0C1CD5141C2</gtr:id><gtr:impact>We aim to publish these methods separately or as part of a larger paper with other results.</gtr:impact><gtr:outcomeId>e21P2BNcfJ7</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis of degraded proteins stored in phenol</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Biobank of clinical samples collected for the IDEA study</gtr:description><gtr:id>25745C96-662B-47AA-BAF8-87F26953F654</gtr:id><gtr:impact>Resource for evaluation and validation of novel TB diagnostics</gtr:impact><gtr:outcomeId>hH4znQfao8D</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>IDEA sample biobank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a robust and reproducible method for the quantification, precipitation and running of human spleen proteins on one and two dimensional electrophoresis gels.</gtr:description><gtr:id>F0489BBB-E743-4986-AD72-76D22DAC3A68</gtr:id><gtr:impact>We aim to publish the methods for this work either separately or together with other findings as part of a larger paper.</gtr:impact><gtr:outcomeId>nK5duqixSPh</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Methods for comparative proteomics of human spleen samples</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Flow cytometry panel to elucidate cytokine secretion of lymphocytes i.e. CD4+T cells, CD8+T cells, NKT cells, NK cells and gamma-delta-T cells based on surface determinants e.g. CD3, CD4, CD8, V?24, CD56 and V?9V?2-TCR and intracellular cytokine staining.</gtr:description><gtr:id>0A5F1B57-3CC1-4B54-BC1D-0B55BF8835FD</gtr:id><gtr:impact>These assays enable to disentangle the contribution of different cell populations to granuloma development in diseases i.e. Sarcoidosis.</gtr:impact><gtr:outcomeId>a8mRtDj2Uvw</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Method for comprehensive lymphocyte flow cytometry</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F78AB73A-CD1B-4BFD-8D86-5F94B71836CE</gtr:id><gtr:title>Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92eaded1a07a59fb7e389434d308ccd0"><gtr:id>92eaded1a07a59fb7e389434d308ccd0</gtr:id><gtr:otherNames>Marriott AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c6b60c9bf224.89668081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>765D9EAD-04A7-48BE-B68F-52D9630580A4</gtr:id><gtr:title>Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5c314c5ff89aa9ff605442935b3d97"><gtr:id>ec5c314c5ff89aa9ff605442935b3d97</gtr:id><gtr:otherNames>Eberhardt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c6a9126e8b57.54487695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>961758DD-9143-4BD8-9EBC-F81CBBE0EA8B</gtr:id><gtr:title>Aeitiology of sarcoidosis</gtr:title><gtr:parentPublicationTitle>Sarcoidosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/678bb0806b792c574ff14678a54c9185"><gtr:id>678bb0806b792c574ff14678a54c9185</gtr:id><gtr:otherNames>Thillai, Muhunthan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>GLYeAac5ZMR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05609A88-5476-481F-8F77-0EA3595F3D7F</gtr:id><gtr:title>Sarcoidosis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9e46358c27c0ba4f15f66a41320d2e1"><gtr:id>b9e46358c27c0ba4f15f66a41320d2e1</gtr:id><gtr:otherNames>Thillai M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-0-340-99211-1</gtr:isbn><gtr:outcomeId>VWWTSYYG1Sd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B9511FC-721A-4FC7-91B7-06556FC27B42</gtr:id><gtr:title>Immunology of sarcoidosis</gtr:title><gtr:parentPublicationTitle>Sarcoidosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2113d0dfda5260d01027897560a4540"><gtr:id>b2113d0dfda5260d01027897560a4540</gtr:id><gtr:otherNames>Moller, David</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>qLJcr2GEeuv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF89303-6F03-4B4C-B83C-9BD710B8085B</gtr:id><gtr:title>The Kveim reaction</gtr:title><gtr:parentPublicationTitle>Sarcoidosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/678bb0806b792c574ff14678a54c9185"><gtr:id>678bb0806b792c574ff14678a54c9185</gtr:id><gtr:otherNames>Thillai, Muhunthan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>gfEmysnDUky</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E76AA5F-DB57-4E5B-B126-C855DFC99E58</gtr:id><gtr:title>Obstructive lung function in sarcoidosis may be missed, especially in older white patients.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9e46358c27c0ba4f15f66a41320d2e1"><gtr:id>b9e46358c27c0ba4f15f66a41320d2e1</gtr:id><gtr:otherNames>Thillai M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>UkkLnofV32x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D5C6792-7F41-4B98-8090-77854939A352</gtr:id><gtr:title>Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9e46358c27c0ba4f15f66a41320d2e1"><gtr:id>b9e46358c27c0ba4f15f66a41320d2e1</gtr:id><gtr:otherNames>Thillai M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15211_21_22815689</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801620</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>